Patients with common but deeply uncomfortable gastrointestinal issues are still struggling to manage their conditions. A Salix-sponsored survey found patients with IBS or chronic constipation saw symptoms worsen—and for some of them, begin—during the pandemic.
A new patient survey from the gastroenterology biopharma dove down into the issues facing people with irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC).